Cancer Stem Cell NewsCancer Stem Cell News
Scientific Literature Review
Research InstitutesThe Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford
The Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford is dedicated to investigating cancer and its treatment from the perspective of stem cell biology and medicine. The view that cancer is driven by cancer stem cells (CSCs) has the capacity to change the whole field of cancer research and lead to entirely new, targeted cancer therapies that cure cancer without the toxicities that are common in most current treatments.
Cancer Stem Cell Research Program at Stanford School of Medicine
(Separate from program above)
The Cancer Stem Cell Research Program brings together leading basic and clinical scientists in a unified effort to understand the origin and nature of cancer stem cells. Found in a number of cancers thus far, these master cells divide uncontrollably, producing new cancer cells and driving the growth and metastasis of tumors.
University of Michigan Comprehensive Cancer Center
The U-M Comprehensive Cancer Center is one of only a few research institutions in the United States and Canada that has made an institutional commitment to cancer stem cell research. Organized teams of U-M scientists are studying cancer stem cells in many different types of cancer - including adrenal, breast, colon, head and neck, leukemia, lung, melanoma, myeloma, pancreatic, prostate and thyroid cancers By working together and sharing information, Cancer Center scientists hope to make progress more rapidly than would be possible for individual scientists working alone.
Whitehead Institute for Biomedical Research, Weinberg Lab
(affiliated with Massachusetts Institute if Technology (MIT))
Studies the role of cancer stem cells-the self-renewing, tumor-seeding cells that have been found in a number of solid tumors in the past few years. In 2008, Weinberg lab investigators reported a finding that brings together these two research themes: cancer cells induced to follow one of these embryonic pathways gain many of the properties of adult stem cells.
The Methodist Hospital Research Institute, Wong Lab
The Methodist Hospital Research Institute was awarded an $11.5 million Center Grant by the National Institutes for Health (NIH) to study the best way to attack deadly cancer stem cells to enhance treatments for breast cancer. Other members of the team include Baylor College of Medicine and the University of Texas Health Science Center at Houston.
Broad Institute (MIT and Harvard collaboration)
The Broad Institute brings together a diverse group of individuals from across its partner institutions - undergraduate and graduate students, postdoctoral fellows, professional scientists, administrative professionals, and academic faculty.
California Institute of Regenerative Medicine
(CIRM) and University of California San Francisco (UCSF)
CIRM grantees at the University of California San Francisco have found the protein certain leukemia cells use to evade chemotherapy.
Stem Cells 2012 February 2-3, 2012 San Diego, Ca
8th Annual Stem Cell Symposium Stem Cells and Cancer: Shared Paths, Different Destinations February 12, 2012 UCLA-Los Angeles, Ca
Targeting Cancer Stem Cells in Oncology (Symposium) February 19-20, 2012 San Francisco, Ca
The 29th Conference on Monoclonal Antibodies and Cancer Stem Cells June 25-27, 2012 Mykonos, Greece
EMBL Conference: Stem Cells in Cancer and Regenerative Medicine EMBL Heidelberg, Germany August 29-September 1 2012
3rd International Conference on Stem Cells and Cancer (ICSCC-2012): Proliferation, Differentiation and Apoptosis October 27-30, 2012 Pune, Maharashtra, India
Over the last decade we have partnered with university researchers, suppliers, and prominent biotechnology companies throughout the world. We are especially thankful for the opportunity to have worked with the following organizations:
Applied StemCell, Inc. | Menlo Park, California
GeneCopoeia, Inc. | Rockville, Maryland
Alstem, LLC | Richmond, California
AllCells, LLC | Alameda, California
Specializing in: Primary Cells, Hematopoietic Cells, Bioservices, Flow Cytometry Services, Genotyping Services, Immunoassay Services, Protein Analysis Services, Stem Cell Assays, Tissue Culture Services
Supreme Optimization | Los Angeles, California
Novoprotein | Summit, NJ
Nvigen | Sunnyvale, California
Sepmag | Barcelona, Spain
Sepmag is a unique provider of magnetic separation devices and instrumentation for the global diagnostics market. Sepmag's instrumentation has been validated for use in a number of diverse applications including diagnostic kit manufacturing, antigen or antibody coupling, affinity protein purification, capture of biotinylated biomolecules, DNA/RNA purification and cell capture/enrichment.